(Q34334943)
Statements
Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101 (English)
Thomas S Lin
Kathleen A Donohue
Margaret S Lucas
Eva E Hoke
Elizabeth M Bengtson
Kanti R Rai
James N Atkins